Developing treatments for injuries caused by radiation exposure
RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT
This study is looking at new ways to help people recover from injuries caused by radiation exposure, using animal tests to see how well these treatments work, with the hope that they can improve care for patients in emergencies like nuclear accidents.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-10302428 on NIH RePORTER |
What this research studies
This research focuses on creating and testing medical countermeasures to treat injuries resulting from radiation exposure. It involves using animal models to evaluate the effectiveness of these treatments and providing samples for biodosimetry studies, which help assess radiation exposure levels. Patients may benefit from advancements in therapies that could mitigate the effects of radiation injuries, particularly in emergency situations involving nuclear incidents.
Who could benefit from this research
Good fit: Ideal candidates would include individuals at risk of radiation exposure, such as those in emergency response roles or living near nuclear facilities.
Not a fit: Patients who have not been exposed to radiation or those with pre-existing conditions unrelated to radiation injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments for patients suffering from radiation injuries.
How similar studies have performed: Similar research has shown promise in developing medical countermeasures for radiation injuries, indicating a potential for success in this area.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Chang, Polly — Sri International
- Study coordinator: Chang, Polly
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.